Normunity Accelco, Inc.
Clinical trials sponsored by Normunity Accelco, Inc., explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New drug NRM-823 takes on Hard-to-Treat cancers Results expected May 2027 (estimated)